Genotropin 5.3 mg (Somatropin POWDER FOR SOLUTION) 5.3 MG

GENOTROPIN 5.3 MG is a somatropin powder for subcutaneous injection, used to address growth hormone deficiencies. This product by Pfizer Canada ULC supports growth and development in individuals with specific medical needs.

Strength

5.3 MG

Pack Size

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

GENOTROPIN 5.3 MG is primarily used to treat growth hormone deficiencies in children and adults. Somatropin, the active ingredient, helps stimulate growth and development. This medication is often prescribed for individuals who do not produce enough growth hormone naturally, impacting their growth and overall health.

Side Effects

Common effects of GENOTROPIN 5.3 MG may include localized reactions at the injection site, such as redness or swelling. Some users might experience joint or muscle pain, headaches, or changes in blood sugar levels. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

GENOTROPIN 5.3 MG should be handled with care, following the prescribed guidelines for preparation and administration. It is important to store the medication properly and use it as directed by a healthcare professional. Regular monitoring may be necessary to ensure its effectiveness and safety.

Avoid Interactions

GENOTROPIN 5.3 MG may interact with other medications, including corticosteroids, thyroid hormones, and insulin. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements might also affect the medication's efficacy.

Frequently Asked Questions

GENOTROPIN 5.3 MG is used to treat growth hormone deficiencies in children and adults, supporting growth and development.

GENOTROPIN 5.3 MG is administered via subcutaneous injection, typically prepared from the powder form as directed.

Common side effects may include localized reactions at the injection site, joint or muscle pain, headaches, and changes in blood sugar levels.

GENOTROPIN 5.3 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

GENOTROPIN 5.3 MG should be stored according to the manufacturer's instructions to maintain its effectiveness and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.